Ocular Surface Disease
📧 Sign up to get email alerts when something new happens for Ocular Surface Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: The Efficacy of Intradermal Acupuncture for Ocular Surface Diseases After Intractable Facial Paralysis [NA]
A clinical trial update notes recruitment for a study evaluating intradermal acupuncture for ocular surface diseases in patients with intrac…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Effect of Acoltremon Ophthalmic Solution 0.003% on Signs and Symptoms of Ocular Surface Disease in Stage I Neurotrophic Keratopathy Patients With Tear Deficiency [Phase 4]
Phase 4 clinical trial evaluating Acoltremon ophthalmic solution 0.003% for signs and symptoms of ocular surface disease in patients with St…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: This is a Single Center, Open-label Prospective Study to Evaluate the Effect of Xiidra® (Lifitegrast Ophthalmic Solution 5.0%) on Tear Film Biomarkers in Dry Eye [Phase 4]
Phase 4 open-label prospective study at a single center to evaluate the effect of Lifitegrast (Xiidra) 5% ophthalmic solution on tear film b…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications
A clinical trial is assessing the treatment of ocular discomfort in glaucoma patients using multiple topical medications. The study is curre…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Eyelid Closure in Keratometry [NA]
A clinical trial sponsored by the Vienna Institute for Research in Ocular Surgery is recruiting for a study on eyelid closure in keratometry…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-19Clinical Trial Update: Study to Evaluating PRO-240 Ophthalmic Solution Compared to Optive® [Phase 1]
Phase 1 clinical trial evaluating PRO-240 ophthalmic solution compared with Optive for dry eye disease; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: Analysis of Videodermatoscopic Parameters of Ocular, Periocular, Conjunctival and Palpebral Neoformations
A clinical study updating on the analysis of videodermatoscopic parameters of ocular and periocular neoformations, with recruitment ongoing …
-
CLINICAL_TRIALS research · 2024-08-15Clinical Trial Update: Clinical Application Research of Scleral Lenses in Ocular Surface Diseases
A clinical trial evaluating scleral lenses for ocular surface diseases is currently recruiting. The study is sponsored by the Second Affilia…
-
CLINICAL_TRIALS research · 2024-07-10Clinical Trial Update: Comparison Between Lathe Cut Versus Cast Molding Soft Contact Lens Technique on Ocular Surface Integrity [NA]
A clinical trial comparing lathe-cut versus cast-molded soft contact lens fabrication techniques to evaluate ocular surface integrity in ocu…
-
CLINICAL_TRIALS research · 2024-06-20Clinical Trial Update: Investigator-initiated Clinical Trial to Observe Conjunctival Goblet Cell Using an Anterior Segment Imaging Device [NA]
An investigator-initiated clinical trial at Seoul National University Hospital is observing conjunctival goblet cells using an anterior segm…
-
CLINICAL_TRIALS research · 2017-01-27Clinical Trial Update: Assessing Ocular Surface Changes After Changing Glaucoma Medications
A completed clinical trial from the University of Colorado, Denver assessed ocular surface changes after switching glaucoma medications. The…
-
CLINICAL_TRIALS research · 2016-09-09Clinical Trial Update: Changes of Visual Function, Ocular Surface Structures and Physiology After Long-Termed Contact Lens Wear [NA]
Clinical trial update assessing changes in visual function and ocular surface structures and physiology after long-term contact lens wear in…
-
CLINICAL_TRIALS research · 2011-01-27Clinical Trial Update: Hydroxypropylmethylcellulose 0.3% and Sodium Hyaluronate 0.18% for Ocular Surface Disease in Glaucoma [NA]
This clinical trial examines a combination of hydroxypropylmethylcellulose 0.3% and sodium hyaluronate 0.18% for ocular surface disease in g…